MSB 3.21% $1.13 mesoblast limited

Ann: Update on BLA for Graft Versus Host Disease, page-674

  1. wot
    10,287 Posts.
    lightbulb Created with Sketch. 1456
    No way they should do a new trial. Focus on heart and back and withdraw compassionate use because according to the Fda it doesn't work, so its unethical to continue supplying it. I'll try reenter again if it can survive this spiralling debt. See you in a year.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.